eNews February 2025
FPN funds scholarship award on CIPN
Tiffany Li, PhD, has been awarded the 2025 Clinical Research Training Scholarship (CRTS) to support her important research on chemotherapy-induced peripheral neuropathy (CIPN). The CRTS is a multi-year scholarship program providing funding for emerging experts in neuropathy, supporting their efforts to advance treatments, prevention, or cures for neuropathy.
FPN welcomes new board members
We are excited to welcome Amanda Peltier, MD, MS, of Vanderbilt University Medical Center, and Shanna Patterson, MD, MS, of Mount Sinai, to our Board of Directors, effective January 1. These two medical experts will help us continue to advance research, advocacy, awareness and education for patients who suffer from neuropathy.
Read more about Dr. Peltier.
Read more about Dr. Patterson.
Anti-MAG neuropathy at-home research opportunity
Those diagnosed with anti-MAG neuropathy are needed to participate in a research study from home. To learn more or sign up, visit: https://sanguinebio.com/condition/anti-mag/?campaign=tpnf or call 617-397-3750 to speak with a research coordinator and see if you qualify.
FPN Webinar: The Value of Genetic Testing for Inherited Neuropathies
Join us on March 3 for an insightful webinar as we explore hereditary neuropathies, with a particular focus on hereditary amyloidosis and the role of genetic testing in diagnosis and treatment. We’ll discuss how these nerve disorders impact the body and the latest advancements in care.
The benefits of adding physical therapy to an exercise routine
For many people with neurologic conditions, physical therapy is an integral part of living with a chronic disease or recovering from injury. It can help reduce disability and boost movement.
Read more about the benefits of physical therapy in Brain & Life.
What makes a drug special?
What makes a drug ‘special?’ This article explores this question, showing how these types of prescription drugs are usually defined by high cost, special handling, or extra care needs – but there’s no clear, consistent definition. This creates confusion, impacts pharmacies differently, and raises concerns about fairness.
Submit your patient story
Do you have an inspiring story to share about your journey with neuropathy? We’d love to hear from you. We’re always looking for inspiring stories to share with our PN community.
